Skip to content
DraconiticResearch
Search Sources API
220,620 studies31 sourcesUpdated 7 min ago

Oncology

5,780 studies504 in 7 days2,684 in 30 days

Filters
Type
Date
Clear

Latest

5,780 studies

  1. The impact of STAS on recurrence-free and overall survival in T1-2N0 adenocarcinomas: a single-center retrospective study
    Şebnem Dursun, Saliha Yılmaz, Yusuf Kahya +6
    BMC CancerPeer-reviewedCC BYFull textOncologyDOAJ
  2. Durvalumab completion and re-administration after grade 2 radiation pneumonitis following concurrent chemoradiotherapy for unresectable stage III NSCLC: a single-center real-world study
    Shuri Aoki, Ryo Ariyasu, Tatsuya Kamima +9
    BMC CancerPeer-reviewedCC BYFull textOncologyDOAJ
  3. Real-world evidence for atezolizumab with bevacizumab for unresectable hepatocellular carcinoma: a multicentre UK Midlands cohort
    Richard Phillips, Harry Daniels, Marie Quinlan +10
    BMC CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. Disulfidptosis-related genes stratify molecular subtypes and highlight MYH9 as a prognostic biomarker and candidate therapeutic target in pancreatic ductal adenocarcinoma
    Xiaoyan Fan, Ming Zhang, Dong Xu +4
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  5. LncRNA KIAA0125 promotes the proliferation of Kasumi-1 cells through the miR-4640-5p/KCNQ1 axis with associated changes in the Wnt/β-catenin signaling pathway
    Huali Hu, Yuancheng Liu, Fahua Deng +9
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  6. Developability engineering of scFvs enables robust CAR function under transient mRNA expression
    Maurizio Mangolini, Aubin Ramon, Bingqian Li +5
    Scientific ReportsPeer-reviewedCC BYFull text1 citedOncologyDOAJ
  7. Serum indocyanine green quantification enables objective assessment of lymphatic function
    Xizhao Chen, Jung Eun Baik, Jinyeon Shin +6
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  8. Cancer survival trends in Shandong Province, China (2016–2024): a population-based study
    Fan Jiang, Junli Tang, Zilong Lu +5
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  9. A photo elicitation study of fear of cancer recurrence and support needs among breast cancer survivors
    Weimin Liu, Yali Su, Han You +4
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  10. Beyond survival: a cross-sectional analysis of guideline recommendations for cognitive, sexual, and psychological problems in adult cancer survivors
    Joshua Ayoson, Nadine Schneider, Brian Casanova +8
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  11. Unveiling GSPT1 as a crucial prognostic biomarker and therapeutic vulnerability in breast cancer
    Huafei Wang, Chenxi Li, Zhu Zhu +6
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  12. The ferroptosis-related LncRNA CASC9 reveals its potential as a diagnostic and prognostic biomarker in esophageal squamous cell carcinoma
    Wu Yaoyao, Lin Qingfeng, Huang Liyou +3
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  13. Identifying potential biomarkers for mild COVID-19 in saliva by miRNA profiling using NGS and ddPCR
    Malena Gajate-Arenas, Candela Sirvent-Blanco, Omar García-Pérez +5
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  14. CLIC4 inhibits the progression of non-small cell lung cancer by suppressing the MAPK pathway
    Pengxiang Gao, Wanjun Lu, Xinyu Tan +2
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  15. Integrative multi-omics analysis of bile acid metabolism as a prognostic determinant in colorectal cancer
    Hamideh Raeisi, Rozita Khodashahi, Mahsa Saeedi Niasar +4
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  16. Chemical characterization and cardiovascular effects of an oxime derived from a metabolite of Senecio nutans
    Javier Palacios, Claudio Parra, Adrián Paredes +7
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  17. Rural–urban differences in mortality from concurrent heart failure and cancer, 2011–2020
    Anum Zehra, Joseph J. Shearer, Maryam Hashemian +4
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  18. Development and external validation of machine learning models for predicting mortality in patients with lung cancer: a multicenter retrospective cohort study
    Lihui Liu, Pan Zuo, Chunlan Yu +7
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  19. An empirically refined workflow for generating patient-derived organoids from epithelial ovarian cancer
    Long Hoang Ngo, Que Thanh Thanh Nguyen, Hanh Thi Tuyet Vo +4
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  20. Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC
    Dorian Espi-Bastien, Judith Raimbourg, Gwenola Bougras-Cartron +13
    Scientific ReportsPeer-reviewedCC BYFull text1 citedOncologyDOAJ
  21. MiR-92a-3p aggravates myocardial injury and cardiac dysfunction in septic cardiomyopathy by inhibiting Dusp1
    Conghui Tao, Yanling Chen, Zheng Zhou +1
    European Journal of Medical ResearchPeer-reviewedCC BYFull textOncologyDOAJ
  22. Radiotherapy and tertiary lymphoid structures: balancing immune activation and immune damage in cancer immunotherapy
    Yi Zhang, Hongshuai Li, Siyao Lv +7
    Molecular CancerPeer-reviewedCC BYFull text5 citedOncologyDOAJ
  23. LncRNA MKRN3-AS1 promotes metastasis and autophagy of hepatocellular carcinoma by sponging multiple microRNAs
    Fei Wang, Jizhe Liu, Gaoxiong Wang +9
    Scientific ReportsPeer-reviewedCC BYFull textOncologyDOAJ
  24. The novel biguanide derivative 4C synergizes with talazoparib by inducing ferroptosis via the SREBP1/FASN/ SLC7A11/GPX4 axis in bladder cancer
    Jia Yao, Weifan Wang, Duo Li +4
    Cell Death DiscoveryPeer-reviewedCC BYFull textOncologyDOAJ
  25. Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study
    Sara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini +19
    npj Precision OncologyPeer-reviewedCC BYFull textOncologyDOAJ